Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia WCN Waste reports slight Q1 2026 EPS beat shares drop 167 percent in regular trading today Southern Company SO Mixed Analyst Price Target Adjustments Amid Utility Sector Outperformance CVS Health CVS Valuation Disparity and Bearish Downside Risks Amid Mixed Share Price Momentum BWNB Babcock 2026 Q4 2025 earnings outperform forecasts as EPS turns positive against projected quarterly loss